Cross Country Healthcare, Inc. (CCRN)
NASDAQHealth CareStaffing & Employment ServicesSnapshot 2026-09-04
$13.250.00%
Close 2026-07-27 · 1-day change
NASDAQHealth CareStaffing & Employment ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · CCRN
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Director — Kevin C. Clark, W. Larry Cash, Venkat Bhamidipati, Dwayne Allen, Gale Fitzgerald and Janice Nevin: Directors resigned in connection with the Merger.
At the Effective Time, a change in control of the Company occurred, and the Company became a wholly-owned subsidiary of Parent. Parent obtained the funds necessary to fund the Merger through a combination of cash on hand, including balance sheet cash of the Company, equity financing and debt financing.
At the Effective Time, each holder of Company Common Stock immediately prior to the Effective Time ceased to have any rights as a Company shareholder other than the right to receive the Merger Consideration pursuant to the Merger Agreement.
Completion of Acquisition or Disposition of Assets. The information set forth in the Introduction and
Termination of a Material Definitive Agreement. Concurrently with the closing of the Merger, the Company discharged all obligations and terminated all credit commitments, security interests and other liens outstanding under the ABL Credit Agreement, dated October 25, 2019, by and among the Company, Wells Fargo Bank, National Association, as administrative and collateral agent, and the lenders party thereto.
In connection with the consummation of the Merger, the Company requested that The Nasdaq Stock Market LLC (“ Nasdaq ”) (i) suspend trading of Company Common Stock on Nasdaq and remove Company Common Stock from listing on Nasdaq, in each case, prior to the opening of the market on July 21, 2026; and (ii) file a notification of removal from listing of Company Common Stock on Form 25 with the Securities and Exchange Commission (“ SEC ”) on July 21, 2026. As a result, trading of Company Common Sh…
Other Events. On June 15, 2026, Cross Country Healthcare, Inc., a Delaware corporation (the “ Company ”), filed a definitive proxy statement (as such may be supplemented from time to time, the “ Proxy Statement ”) with the Securities and Exchange Commission (the “ SEC ”) with respect to the special meeting of the Company’s stockholders (the “ Special Meeting ”) to be held in connection with transactions contemplated by that certain Agreement and Plan of Merger (the “ Merger Agreement ”) by an…
Other Events. As previously disclosed, on May 6, 2026, Cross Country Healthcare, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among the Company, KL Criss Cross Intermediate, LLC, a Delaware limited liability company (“ Parent ”), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“ Merger Sub ”), pursuant to which Merger Sub will merge with and into the Company (…
Results of Operations and Financial Condition (a) On May 7, 2026, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended March 31, 2026, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under
Other Events In consideration of the proposed Merger, the Company is canceling its earnings conference call to discuss its first quarter 2026 financial results, which was previously scheduled to be held on May 7, 2026. Additionally, the Board has determined to cancel the Company’s 2026 Annual Meeting of Stockholders (the “ 2026 Annual Meeting ”), which was previously scheduled to be held virtually on May 11, 2026, and to withdraw from consideration by the Company’s stockholders the proposals…
Entry Into a Material Definitive Agreement. Agreement and Plan of Merger On May 6, 2026, Cross Country Healthcare, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and among the Company, KL Criss Cross Intermediate, LLC, a Delaware limited liability company (“ Parent ”), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), pursuant to which Merger Sub wil…
Chief Operating Officer — Amiee Hawkins: Ms. Hawkins was promoted to Chief Operating Officer from her previous role as Chief Solutions and Operations Officer.
Chief Information Officer — Phil Noe: Mr. Noe ceased to serve as the Chief Information Officer and entered into a Separation Agreement with severance payments.
Senior Vice President and Chief Accounting Officer — James V. Redd III: Mr. Redd's departure is a genuine loss of a senior executive.
Results of Operations and Financial Condition (a) On March 4, 2026, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the fourth quarter and full year ended December 31, 2025, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under
President and CEO — Mr. Clark: Mr. Clark was promoted to President and CEO with a detailed employment agreement.
CEO — John A. Martins: John A. Martins separated from the Company and ceased to serve as CEO, with Kevin C. Clark appointed as President and CEO.
Termination of a Material Definitive Agreement. As previously disclosed, on December 3, 2024, Cross Country Healthcare, Inc. (the “ Company ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Aya Holdings II Inc. (“ Parent ”), Spark Merger Sub One Inc., a wholly owned subsidiary of Parent, and, solely for the limited purposes set forth therein, Aya Healthcare, Inc., providing for, subject to the satisfaction or waiver of certain conditions, the acquisition of the C…
Results of Operations and Financial Condition (a) On November 12, 2025, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended September 30, 2025, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under
Other Events On September 3, 2025, in accordance with the terms of the Agreement and Plan of Merger, dated as of December 3, 2024 (as may be amended from time to time by the parties thereto, the “ Merger Agreement ”), among Cross Country Healthcare, Inc. (the “ Company ”), Aya Holdings II Inc. (“ Parent ”), Spark Merger Sub One Inc., a wholly owned subsidiary of Parent (“ Merger Sub ”), and, solely for the limited purposes set forth therein, Aya Healthcare, Inc., pursuant to which Merger Sub…
Results of Operations and Financial Condition (a) On August 6, 2025, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended June 30, 2025, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under
Results of Operations and Financial Condition (a) On May 7, 2025, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended March 31, 2025, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under
Results of Operations and Financial Condition (a) On March 5, 2025, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the fourth quarter and full year ended December 31, 2024, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under
Results of Operations and Financial Condition (a) On November 6, 2024, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended September 30, 2024, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under
Results of Operations and Financial Condition (a) On July 31, 2024, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended June 30, 2024, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.